Friday, September 30, 2011

ben goldacre: battling bad science

While I don't agree with everything he has to say, he makes some really good points about how research is skewed for financial gain by the pharmaceutical industry. Worth watching.

On the other hand, these are not the only valid research methods and "hard science" isn't always so clear cut. Anecdotal evidence is also worth noting.

Only those with LOTS of money can perform the kind of control group studies that he discusses--and get them published.



1 comment:

Kathryn Grace said...

Enlightening, and mostly not surprising. What did surprise me was his assertion that many comparison drug trials are rigged grossly unfairly, with dosages of the unfavored drug so low or so high as to completely skew the results in favor of the trial drug, which of course was administered in appropriate dosages.

Useless FDA.